Abstract: Disclosed are probiotic formulations. The formulations of the present disclosure comprise microorganisms of the species Pediococcus acidilactici and Leuconostoc mesenteroides. The formulations of the present disclosure can be used to prevent or treat gastrointestinal disease conditions, notably gastrointestinal diseases associated with low gastrointestinal mannitol or infection of the gastrointestinal system by pathogenic organismsC.
Type:
Grant
Filed:
December 4, 2018
Date of Patent:
December 26, 2023
Assignee:
The Biocollective, LLC
Inventors:
Martha Rodgers Carlin, Steven Karim Kazemi, Naseer Sangwan, Raul De Jesus Cano